MB

Mit Bhagvanjibhai Bhadja

Active Director Director DIN 11585567
DIN 11585567 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mit Bhagvanjibhai Bhadja

Data last updated:

Mit Bhagvanjibhai Bhadja is a Director at Maygen Pharmaceuticals Private Limited (since 2026).

DIN 11585567
Primary Designation Director
First Appointment 05 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Mar 20262026Active

Directorship timeline

Open interactive timeline →
Maygen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mit Bhagvanjibhai Bhadja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mit Bhagvanjibhai Bhadja

Mit Bhagvanjibhai Bhadja currently holds 1 directorship: Maygen Pharmaceuticals Private Limited (Director, since 05 Mar 2026).

Mit Bhagvanjibhai Bhadja was first appointed on 05 Mar 2026 as Director at Maygen Pharmaceuticals Private Limited.

The current boards of Mit Bhagvanjibhai Bhadja's companies include Anup Ramesh Agrawal (Maygen Pharmaceuticals Private Limited), Kanhaiya Purushottam Agrawal (Maygen Pharmaceuticals Private Limited), Mayank Rajesh Agrawal (Maygen Pharmaceuticals Private Limited), Rajesh Maheshchandra Agrawal (Maygen Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available